Welcome to our dedicated page for IACC.U news (Ticker: IACC.U), a resource for investors and traders seeking the latest updates and insights on IACC.U stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IACC.U's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IACC.U's position in the market.
ION Acquisition Corp 3 Ltd. has priced its initial public offering of 22,000,000 Class A ordinary shares at $10.00 each, with trading set to begin on April 30, 2021, under the ticker symbol IACC on the New York Stock Exchange. The offering is expected to close on May 4, 2021. This blank check company aims to pursue business combinations primarily with Israeli companies leveraging technology and innovation. Morgan Stanley and Goldman Sachs are the joint book-running managers, with an additional 3,300,000 shares available for purchase by underwriters to cover over-allotments.
